Investing.com - Amgen reported second quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $3.97 on revenue of $5.87B. Analysts polled by Investing.com expected EPS of $3.59 on revenue of $5.68B. That compared to EPS of $3.83 on revenue of $6.06B in the same period a year earlier. The company had reported EPS of $3.56 on revenue of $5.56B in the previous quarter.
Amgen shares gained 2.56% to trade at $180.96 in after-hours trade following the report.
Amgen follows other major Healthcare sector earnings this month
On July 16, J&J reported second quarter EPS of $2.58 on revenue of $20.56B, compared to forecasts of EPS of $2.46 on revenue of $20.29B.
Pfizer earnings beat analysts' expectations on Monday, with second quarter EPS of $0.8 on revenue of $13.26B. Investing.com analysts expected EPS of $0.75 on revenue of $13.41B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar